ArticleOncogene2018

Histone methyltransferase KMT2D sustains prostate carcinogenesis and metastasis via epigenetically activating LIFR and KLF4.

Shidong Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.